Work

Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas

Year: 1990

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/bf00216936

Authors: Robert H. Earhart, David J. Amato, Alex Yuang-Chi Chang, Ernest C. Borden, Masanori Shiraki, Melissa E. Dowd, Robert L. Comis, Thomas E. Davis, Thomas J. Smith

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Harvard University, Dana-Farber Cancer Institute, University of Rochester Medicine, University of Rochester, Tufts University, Fox Chase Cancer Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G1257575315, G1422427855, Southwest Oncology Group, G721629745, EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES, ECOG Statistical Office

OpenAlex ID: W2042680956

FWCI: 1.083

Cites: 32

Cited by: 71

Related to: 10